Drug Pipeline

BI 764532 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
9
Active Studies
2
Recruiting
2
Phase 3
2
Top Sponsors
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT05916313
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a…
Enrollment increased: 18 -> 20 participants
2026-06-10 NCT06132113
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to…
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-03 NCT05916313
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a…
date change Primary completion pushed: 2026-05-23 -> 2027-08-09
2026-06-03 NCT05916313
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a…
date change Completion pushed: 2026-06-30 -> 2027-09-30
2026-05-30 NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare…
Trial sites expanded: 232 -> 235 locations
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07472517 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare… Small Cell Lung Cancer (SCLC) Recruiting
NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to… Extrapulmonary Neuroendocrine Cancer Not Yet Recruiting
Phase 2
NCT07561645 A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung Large Cell Neuroendocrine Carcinoma of the Lung Not Yet Recruiting
Phase 1
NCT05963867 A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung… Small Cell Lung Carcinoma (SCLC) Recruiting
NCT05990738 DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People… Small Cell Lung Carcinoma (SCLC) Active, Not Recruiting
NCT05879978 A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With… Small Cell Lung Carcinoma (SCLC) Active, Not Recruiting
NCT05916313 A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a… Glioma Active, Not Recruiting
NCT06077500 DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard… Small Cell Lung Carcinoma (SCLC) Active, Not Recruiting
NCT06132113 DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to… Neuroendocrine Neoplasms Active, Not Recruiting
Sponsors Running BI 764532 Trials
Disease Areas
Get alerts when BI 764532 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free